Anti-BCL10 Antibody

The B-cell lymphoma/leukemia 10 (BCL10) protein functions as a CARD-containing adaptor in antigen receptor-mediated NF-κB signaling and has been linked to lymphocyte activation, apoptosis regulation, and MALT lymphoma pathogenesis. This rabbit polyclonal reagent from Antibodies.com, supplied as 100 µl of unconjugated antiserum, enables Western blot, immunohistochemistry, and immunofluorescence workflows against endogenous BCL10 in human, mouse, and rat samples. Researchers studying MALT lymphoma translocations, NF-κB pathway dysregulation, or T-cell receptor signalosome assembly can use this antibody to probe CARD11–BCL10–MALT1 (CBM) complex formation, caspase recruitment domain interactions, and downstream IκB kinase activation across cell culture and tissue-derived specimens.